Citalopram plus reboxetine in treatment-resistant depression
Devarajan, S.; Dursun, S.M.
Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 45(5): 489-490
2000
ISSN/ISBN: 0706-7437 PMID: 10900531 Document Number: 520577
Document emailed within 1 workday
Related Documents
Montgomery, S.A.; Schatzberg, A.F. 1998: Introduction. Reboxetine: a new selective antidepressant for the treatment of depression Journal of Clinical Psychiatry 59 Suppl. 14: 3Chue, P. 2000: Reboxetine and treatment-refractory elderly patients with depression Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 45(7): 669
1998: Citalopram for depression Medical Letter on Drugs and Therapeutics 40(1041): 113-114
Speer, L. 2015: Citalopram Plus Methylphenidate Better Than Either Alone for Geriatric Depression American Family Physician 92(9): 820-820
Pallanti, S.; Quercioli, L.; Koran, L.M. 2002: Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial Journal of Clinical Psychiatry 63(9): 796-801
Keller, M.B. 2000: Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials Journal of Clinical Psychiatry 61(12): 896-908
Schwan, S.; Hallberg, P.är. 2009: Escitalopram versus citalopram in true depression. Review of studies do not support clinically relevant differences of the effect Lakartidningen 106(12): 858-861
Ballas, C.; Staab, J.P.; Evans, D.L. 2002: Strategies for treatment-resistant depression Psychopharmacology Bulletin 36(4): 39-62
Taiminen, T. 2013: Treatment of drug-resistant depression Duodecim; Laaketieteellinen Aikakauskirja 129(20): 2149-2156
Keller, M.B. 2005: Issues in treatment-resistant depression Journal of Clinical Psychiatry 66 Suppl. 8: 5-12
Karadağ, F.; Tan, D.; Unal, F. 2011: Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports Turk Psikiyatri Dergisi 22(4): 269-272
2011: Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice Prescrire International 20(116): 128-133
Lydiard, R.B. 1985: Tricyclic-resistant depression: treatment resistance or inadequate treatment? Journal of Clinical Psychiatry 46(10): 412-417
Jakuszkowiak-Wojten, K.; Gałuszko-Węgielnik, M.; Wilkowska, A.; Słupski, J.; Włodarczyk, A.; Górska, N.; Szarmach, J.; Szałach, Łu.P.; Wiglusz, M.S.; Krysta, K.; Cubała, W.ła.J. 2019: Suicidality in treatment resistant depression: perspective for ketamine use Psychiatria Danubina 31(Suppl 3): 258-260
Inoue, K. 2010: Cognitive-behavioral therapy for treatment-resistant depression Seishin Shinkeigaku Zasshi 112(11): 1097-1104
Wager, S.G.; Klein, D.F. 1988: Drug therapy strategies for treatment-resistant depression Psychopharmacology Bulletin 24(1): 69-74
Marangell, L.B. 2001: Switching antidepressants for treatment-resistant major depression Journal of Clinical Psychiatry 62(Suppl): 12-17
Faust, V.; Hole, G.; Wolfersdorf, M. 1986: So-called therapy-resistant depression. Causes and treatment possibilities Fortschritte der Medizin 104(23-24): 465-468
Fava, M. 2001: Augmentation and combination strategies in treatment-resistant depression Journal of Clinical Psychiatry 62(Suppl): 4-11
Kielholz, P. 1990: Treatment of drug-resistant depression by intravenous administration of antidepressants Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(4): 53-56